blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1424343

EP1424343 - Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.07.2005
Database last updated on 28.06.2024
Most recent event   Tooltip29.07.2005Application deemed to be withdrawnpublished on 14.09.2005  [2005/37]
Applicant(s)For all designated states
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Im Neuenheimer Feld 280
69120 Heidelberg / DE
[N/P]
Former [2004/23]For all designated states
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Im Neuenheimer Feld 280
69120 Heidelberg / DE
Inventor(s)01 / Heckl, Stefan
Steubenstr. 28
69120 Heidelberg / DE
02 / Braun, Dr. Klaus
Bruchhausen 1B
69207 Sandhausen / DE
03 / Pipkorn, Dr. Rüdiger
Adolf-Rauch-Str. 3
69124 Heidelberg / DE
04 / Waldeck, Waldemar Dr.
Tilsiter Str. 49
69514 Laudenbach / DE
 [2004/23]
Representative(s)Schüssler, Andrea
Kanzlei Huber & Schüssler
Truderinger Strasse 246
81825 München / DE
[N/P]
Former [2004/23]Schüssler, Andrea, Dr.
Kanzlei Huber & Schüssler Truderinger Strasse 246
81825 München / DE
Application number, filing date02026700.129.11.2002
[2004/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1424343
Date:02.06.2004
Language:EN
[2004/23]
Search report(s)(Supplementary) European search report - dispatched on:EP29.07.2003
ClassificationIPC:C07K14/47, A61K49/14, A61K47/48, A61P35/00
[2004/23]
CPC:
C12N15/62 (EP,US); A61K47/64 (EP,US); A61K49/085 (EP,US);
A61K49/14 (EP,US); A61K51/088 (EP,US); A61P35/00 (EP);
C07K19/00 (EP,US); C07K2319/02 (EP,US); C07K2319/03 (EP,US);
C07K2319/09 (EP,US) (-)
Designated contracting states(deleted) [2005/08]
Former [2004/23]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SK,  TR 
TitleGerman:Peptidkonjugat zur molekularen Zellkernabbildung oder Tumorbehandlung[2004/23]
English:Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy[2004/23]
French:Conjugué peptidique pour l'imagerie moléculaire des noyeux cellulaires et la thérapie des tumeurs[2004/23]
Examination procedure03.12.2004Application deemed to be withdrawn, date of legal effect  [2005/37]
05.04.2005Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2005/37]
Fees paidRenewal fee
30.11.2004Renewal fee patent year 03
Penalty fee
Penalty fee Rule 85a EPC 1973
13.01.2005AT   M01   Not yet paid
13.01.2005BE   M01   Not yet paid
13.01.2005BG   M01   Not yet paid
13.01.2005CH   M01   Not yet paid
13.01.2005CY   M01   Not yet paid
13.01.2005CZ   M01   Not yet paid
13.01.2005DE   M01   Not yet paid
13.01.2005DK   M01   Not yet paid
13.01.2005EE   M01   Not yet paid
13.01.2005ES   M01   Not yet paid
13.01.2005FI   M01   Not yet paid
13.01.2005FR   M01   Not yet paid
13.01.2005GB   M01   Not yet paid
13.01.2005GR   M01   Not yet paid
13.01.2005IE   M01   Not yet paid
13.01.2005IT   M01   Not yet paid
13.01.2005LU   M01   Not yet paid
13.01.2005MC   M01   Not yet paid
13.01.2005NL   M01   Not yet paid
13.01.2005PT   M01   Not yet paid
13.01.2005SE   M01   Not yet paid
13.01.2005SK   M01   Not yet paid
13.01.2005TR   M01   Not yet paid
Penalty fee Rule 85b EPC 1973
13.01.2005M01   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9534295  (UNIV VANDERBILT [US]) [Y] 1-3,5-16 * page 6, second paragraph; page 11, first paragraph; claims 11-15 *;
 [Y]  - HEIJNE VON G ET AL, "SPECIES-SPECIFIC VARIATION IN SIGNAL PEPTIDE DESIGN IMPLICATIONS FOR PROTEIN SECRETION IN FOREIGN HOSTS", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (198902), vol. 244, no. 2, ISSN 0014-5793, pages 439 - 446, XP001149430 [Y] 1-3,5-16 * page 439, left-hand column, second paragraph; page 439, right-hand column, last paragraph *

DOI:   http://dx.doi.org/10.1016/0014-5793(89)80579-4
 [Y]  - BRAUN K ET AL, "A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (2002), vol. 318, no. 2, ISSN 0022-2836, pages 237 - 243, XP002238940 [Y] 5-10 * abstract; table 1; page 242, left-hand columns, lines 5-9 *

DOI:   http://dx.doi.org/10.1016/S0022-2836(02)00031-1
 [Y]  - BHORADE RAJEEV ET AL, "Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide.", BIOCONJUGATE CHEMISTRY, (200005), vol. 11, no. 3, ISSN 1043-1802, pages 301 - 305, XP002242549 [Y] 2,12-14 * abstract; page 301, right-hand column, lines 5-8; page 302, left-hand column, lines 1-4; figure 3 *

DOI:   http://dx.doi.org/10.1021/bc990168d
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.